Loading...
Search Filters
Date Range
toReport Types
Condition
See all (43)
Region of the Body
See all (17)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 20 of 433
IV and/or IA TXA effective in navigated TKA, but combined IV-IA TXA not more effective
J Arthroplasty. 2017 Jan;32(1):37-42
IV and topical TXA superior to placebo for hematological outcomes after PLIF
World Neurosurg. 2019 Feb;122:e821-e827.
Non-inferior efficacy of topical TXA to IV TXA in total knee arthroplasty patients
J Arthroplasty. 2014 Aug;29(8):1528-31
Efficacy of combined IV/IA TXA administration in simultaneous bilateral TKA
Knee. 2015 Mar;22(2):131-5
IV and topical tranexamic acid protocols reduce blood loss and transfusion needs in THA
J Arthroplasty. 2018 Oct;33(10):3083-3089.e4. doi: 10.1016/j.arth.2018.06.023
IV & topical TXA similarly safe & effective for reducing blood loss and transfusion in TKA
J Orthop. 2016 Mar 26;13(3):127-31
Similar blood loss and lower cost with oral TXA vs. both IA TXA and IV TXA in total hip arthroplasty
J Arthroplasty. 2018 Mar;33(3):786-793
Lower blood loss with IV+IA TXA versus IV TXA alone following total knee arthroplasty
J Bone Joint Surg Am. 2016 May 18;98(10):835-41
Combined IV & topical TXA reduces blood loss and transfusion rate in THA
J Bone Joint Surg Am. 2016 Jun 15;98(12):983-91
Increasing number of IV TXA doses further improves efficacy without increasing VTE risk in THA
J Arthroplasty. 2018 Sep;33(9):2940-2945. doi: 10.1016/j.arth.2018.04.024
Topical TXA reduces blood loss compared to IV TXA in bilateral total knee arthroplasty
J Arthroplasty. 2016 Jul;31(7):1442-8
Showing 1 - 20 of 433